Sangram Kale

Company: Biosynth

Job title: Head of Peptide Discovery

Seminars:

Targeted Radiotherapy using CLIPS™ Macrocyclic Peptides: The case of PSV359 2:00 pm

Discovery, development and preclinical study of [²¹²Pb] PSV359 macrocyclic peptide against FAPα protein Targeting tumor receptors with an on-cell macrocyclic peptide screening platform Macrocyclic CLIPS™ peptide discovery and optimization platform for radioligand therapyRead more

day: P&T Track PM